GENEVA, July 2 -- GROOVY MEDICINE (HANGZHOU) LTD. filed a patent application (CN2025/135393) for “SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF CHECKPOINT KINASE 1 AND NOTCH SIGNALING PATHWAY AND USES THEREOF”. With publication no. WO/2026/108771, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: A61P 35/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....